The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension

By Thomas G. Neil  

Drugs & Aging, Vol. 23, Iss. 2, 2006-01 ,pp. : 131-155

Adis International

Access to resources Recommend Favorite

The role of pharmacoeconomics in decision-making

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

The Telmisartan Renoprotective Study from Incipient Nephropathy to Overt Nephropathy – Rationale, Study Design, Treatment Plan and Baseline Characteristics of the Incipient to Overt: Angiotensin II Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study

By Makino H   Haneda M   Babazono T   Moriya T   Ito S   Iwamoto Y   Kawamori R   Takeuchi M   Katayama S  

The Journal of International Medical Research, Vol. 33, Iss. 6, 2005-11 ,pp. : 677-686

Field House Publishing

Access to resources Recommend Favorite

Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years

By Gradman Alan H.  

Drugs & Aging, Vol. 26, Iss. 9, 2009-09 ,pp. : 751-767

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics in Healthcare Decision Making in China

By Li Hai-tao  

Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. : 279-282

Adis International

Access to resources Recommend Favorite